Predicts the National Cancer Institute Will Show Myeloma Survival Has Improved by 25%!  But Carnac sees a 50% Improvement!

Every  April 15 is not only tax day, but it is the date when the National Cancer Institute publishes the new year’s data for survival for multiple myeloma.  One of the short falls to this publication is that they publish in April of 2015, and the earliest information is for 2011.  They should be able to provide one year survival for 2013, but they do not and I have no idea why they are at least 3 years behind.  The newest data was published on 4/15, however the relative survival statistics has yet to be updated, so as yet we have no new survival update for 2011.  So like Johnny Carson as Carnac The Magnificent


I will predict this year’s number and that of next year as well.  First lets look at the history of the survival for myeloma in the USA. 

year             survival milestones        years between milestones

1975                     2 years                               –

                     3 years                             13

                     4 years                               6

(Carnac        5 years                              4


For the last 4 years the average life expectancy has not changed, however if you look at newly diagnosed from 1975 to 2004 it has improved by 100% from 2 years to 4 years.  And although the National Cancer Institute has not
published the survival statistics as yet for 2007, I am confident it will again be 4 years, however Carnac predicts it will reach 5 years of survival for the 2008 newly diagnosed patients which will be published in April of 2016 by the NCI.  You can see the most recent data on survival published by the National Cancer Institute if you CLICK HERE.  You will note the earliest year with data is 2010. 

I think the most important finding in the SEER data is that the time between milestones has gone from 13 years to just 4 years, and if this trend continues at the current rate, patients should see the next mile
stone of 6 year survival no later than when the 2012 newly diagnosed patients reach their 6th year.  What I am most excited about is that the numbers are starting to reflect the current advancements and the acceleration of these advancements.   Carnac The Magnificent will go so far as to predict the average life expectancy for those patients newly diagnosed in 2015 will have an average life expectancy of 7 years.  And has been the case, those who find one of the many exceptional multiple myeloma specialists will average as many as 14 years, which happens to be just two years shy of the predicted life expectancy of a 69 year old without myeloma, and 69 is the average age of a myeloma patient.

as of 4/23/2015 –  The NCI has published the new year data (CLICK HERE)  and Carnac was correct the survival remained at 4 years.  However it did show the 4 year survival at 54.8%, so it looks like there is a high probability that next year will show a 5 year survival.  Because average survival of 50% is something greater than 4 years and less than 5 years you can make the argument that it is now just shy of 4.5 years or a 12.5% improvement year over year.

Good luck and may God Bless your Cancer Journey.   For more information on multiple myeloma survival rates and treatments CLICK HERE and you can follow me on twitter at:

About the Author